Publicaciones (328) Publicaciones de JOSÉ LUIS RODICIO DÍAZ

2016

  1. Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: Rationale for further study on blood pressure targets of antihypertensive treatment after stroke

    Journal of Hypertension, Vol. 34, Núm. 3, pp. 393-396

2014

  1. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: Design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1888-1897

  2. Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: A review of available trial evidence

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1741-1750

2009

  1. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document

    Journal of Hypertension, Vol. 27, Núm. 11, pp. 2121-2158

  2. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force documental

    Blood Pressure, Vol. 18, Núm. 6, pp. 308-347

2007

  1. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: The OLMEBEST study

    Clinical Drug Investigation, Vol. 27, Núm. 8, pp. 545-558

  2. Evolution of blood pressure control in Spain [2]

    Journal of Hypertension

  3. Recomendaciones para la detección y el tratamiento del anciano con hipertensión arterial

    Nefrologia, Vol. 27, Núm. 3, pp. 270-278

2006

  1. Aldosterone and its blockade: a cardiovascular and renal perspective.

    TheScientificWorldJournal, Vol. 6, pp. 413-424

  2. La insuficiencia renal como factor de riesgo cardiovascular

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 103, Núm. 4, pp. 145-147

2005

  1. Do we need to target 'prediabetic' hypertensive patients?

    Journal of Hypertension, Vol. 23, Núm. 12, pp. 2119-2125

  2. Guía Europea de Prevención Cardiovascular en la Práctica Clínica

    Clínica e investigación en arteriosclerosis, Vol. 17, Núm. 1, pp. 21-33

  3. High blood pressure, alcohol and cardiovascular risk

    Journal of Hypertension, Vol. 23, Núm. 1, pp. 226-229

  4. High blood pressure, smoking and cardiovascular risk

    Journal of Hypertension, Vol. 23, Núm. 1, pp. 219-221

  5. Treatment of hypertension in dialysed patients

    Journal of Hypertension, Vol. 23, Núm. 1, pp. 222-226

2004

  1. Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: A prospective randomized placebo-controlled 2-year study

    Transplantation, Vol. 78, Núm. 8, pp. 1204-1211

  2. Development of chronic kidney disease and cardiovascular prognosis in essential hypertensive patients

    Journal of the American Society of Nephrology, Vol. 15, Núm. 6, pp. 1616-1622

  3. Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial

    Journal of Hypertension, Vol. 22, Núm. 4, pp. 847-857

  4. Erratum: European guidelines on cardiovascular disease prevention in clinical practice (Atherosclerosis (2003) 171 (145-155) DOI: 10.1016/S0021-9150(03)00419-2)

    Atherosclerosis

  5. European guidelines on cardiovascular disease prevention in clinical practice

    Archives des Maladies du Coeur et des Vaisseaux, Vol. 97, Núm. 10, pp. 1019-1030